Skip to main content

Barnsley

Final Response (rather comprehensive).


Dear Nick

In response to your request for information I have received the following details:-

The Barnsley CCG has a Freestyle Libre within its Formulary and an initiation plan in place via protocols.

1) Current Barnsley protocols for adults and children – web links are provided below. These are currently being amended in line with national guidance ( Feb 19)  in respect of eligible patients. This amended draft guidance is currently being considered by the Local Medical Committee with the aim of being endorsed by the Barnsley Area Prescribing Committee at the beginning of May 2019.

http://best.barnsleyccg.nhs.uk/clinical-support/medicines/shared-care-guidelines/Freestyle_Libre_Protocol.pdf

http://best.barnsleyccg.nhs.uk/clinical-support/medicines/shared-care-guidelines/Freestyle_Libre_protocol_children.pdf

2) Its proposed that Freestyle Libre supply will remain Amber  - as currently with first six months prescribing through specialist nursing teams to support patients and then stable patients would be appropriately referred over to GP practice to manage supplies under the shared care protocol. 

Could I clarify that in Barnsley the Red, Amber, Green listing is not a restriction on supply.  It is a classification which denotes where prescription supplies would be obtained from/ where the responsibility for prescribing supply is  :-

Red –  only specialists would supply

Amber – Specialists only to initiate and primary care clinicians via shared care ( oversight with specialists)

Amber G – Specialist initiate but does not require ongoing specialist oversight

Green – hospital and primary care clinicians can prescribe

It is the Formulary which restricts supply and Freestyle Libre is included within the Formulary and available to be prescribed to patients overseen by the most appropriate clinicians.

The majority of prescribing is being made in Barnsley via specialist nursing teams who are supporting patients. It is for this reason that there is currently little supply through FP10 prescription. As more patients become stable and are handed over to GP practices via the protocol then the amount prescribed will increase.

Comments

Popular posts from this blog

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results. Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too) .  The major piece of work with respect to this is finding the right person to contact.  However, I have s

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m

July Update - CCGs Under Pressure!

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 d